Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765)

Cynthia X. Ma; Shirong Cai; Shunqiang Li; Christine E. Ryan; Zhanfang Guo; W. Timothy Schaiff; Li Lin; Jeremy Hoog; Reece J. Goiffon; Aleix Prat; Rebecca L. Aft; Matthew J. Ellis; Helen Piwnica-Worms

doi:10.1172/JCI64256

Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765)

Cynthia X. Ma, Shirong Cai, Shunqiang Li, Christine E. Ryan, Zhanfang Guo, W. Timothy Schaiff, Li Lin, Jeremy Hoog, Reece J. Goiffon, Aleix Prat, Rebecca L. Aft, Matthew J. Ellis, Helen Piwnica-Worms

Cancer Biology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	2702
Number of pages	1
Journal	Journal of Clinical Investigation
Volume	122
Issue number	7
DOIs	https://doi.org/10.1172/JCI64256
State	Published - Jul 2 2012

ASJC Scopus subject areas

General Medicine

Access to Document

10.1172/JCI64256

Cite this

Ma, C. X., Cai, S., Li, S., Ryan, C. E., Guo, Z., Schaiff, W. T., Lin, L., Hoog, J., Goiffon, R. J., Prat, A., Aft, R. L., Ellis, M. J., & Piwnica-Worms, H. (2012). Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765). Journal of Clinical Investigation, 122(7), 2702. https://doi.org/10.1172/JCI64256

Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765). / Ma, Cynthia X.; Cai, Shirong; Li, Shunqiang et al.
In: Journal of Clinical Investigation, Vol. 122, No. 7, 02.07.2012, p. 2702.

Research output: Contribution to journal › Comment/debate › peer-review

Ma, CX, Cai, S, Li, S, Ryan, CE, Guo, Z, Schaiff, WT, Lin, L, Hoog, J, Goiffon, RJ, Prat, A, Aft, RL, Ellis, MJ & Piwnica-Worms, H 2012, 'Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765)', Journal of Clinical Investigation, vol. 122, no. 7, pp. 2702. https://doi.org/10.1172/JCI64256

@article{664360ce275b42b5bf51e1570937e9dc,

title = "Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765)",

author = "Ma, {Cynthia X.} and Shirong Cai and Shunqiang Li and Ryan, {Christine E.} and Zhanfang Guo and Schaiff, {W. Timothy} and Li Lin and Jeremy Hoog and Goiffon, {Reece J.} and Aleix Prat and Aft, {Rebecca L.} and Ellis, {Matthew J.} and Helen Piwnica-Worms",

year = "2012",

month = jul,

day = "2",

doi = "10.1172/JCI64256",

language = "English (US)",

volume = "122",

pages = "2702",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "The American Society for Clinical Investigation",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765)

AU - Ma, Cynthia X.

AU - Cai, Shirong

AU - Li, Shunqiang

AU - Ryan, Christine E.

AU - Guo, Zhanfang

AU - Schaiff, W. Timothy

AU - Lin, Li

AU - Hoog, Jeremy

AU - Goiffon, Reece J.

AU - Prat, Aleix

AU - Aft, Rebecca L.

AU - Ellis, Matthew J.

AU - Piwnica-Worms, Helen

PY - 2012/7/2

Y1 - 2012/7/2

UR - http://www.scopus.com/inward/record.url?scp=84863544951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863544951&partnerID=8YFLogxK

U2 - 10.1172/JCI64256

DO - 10.1172/JCI64256

M3 - Comment/debate

AN - SCOPUS:84863544951

SN - 0021-9738

VL - 122

SP - 2702

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 7

ER -

Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this